El Salvador vs Saudi Arabia: Previously treated cases tested for RR-/MDR-TB
El Salvador
97.0%
in 2024
Saudi Arabia
98.0%
in 2024
El Salvador rank
61st
Saudi Arabia rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- El Salvador
- Saudi Arabia
How they compare
Saudi Arabia currently reports 98.0% against 97.0% in El Salvador, a difference of 1.0%.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was El Salvador ahead.
El Salvador ranks 61st and Saudi Arabia ranks 58th of 180 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.0% | 52.2% | 14.2% | Saudi Arabia |
| 2020s | 45.0% | 70.6% | 25.6% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, El Salvador or Saudi Arabia?
- Saudi Arabia, at 98.0% against 97.0% in El Salvador as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between El Salvador and Saudi Arabia?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for El Salvador and Saudi Arabia?
- 12 years are reported by both, from 2013 to 2024.
- How do El Salvador and Saudi Arabia rank globally for previously treated cases tested for rr-/mdr-tb?
- El Salvador ranks 61st and Saudi Arabia ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.